Replies to post #3628 on Revance Therapeutics Inc (RVNC)

[iwfal]

I've already read it. I know forntalis is tricky but I just think my expectation about daxxify was too high .

I’d be surprised if the Dax *proportionate* duration advantage is much different. Ie I suspect that traditional botulinum toxins also have shorter duration in frontalis - hence, for instance, not being in Dysport label.

That said, it’s possible there are some dose or injection site optimizations that are still suboptimal for Dax vs Botox etc. But that seems less likely as the primary issue?